Bausch Says Investors' Price-Gouging Claims Came Too Late

Law360 (June 1, 2020, 8:56 PM EDT) -- Bausch Health Cos. Inc. and its brass on Friday sought to shed a securities fraud lawsuit that alleges the company engaged in a price-gouging scheme that cost investors billions, telling a New Jersey federal judge that investors' claims came too late.

In its May 29 brief supporting its motion to dismiss the lawsuit filed by an affiliated group of institutional investors, Bausch told U.S. District Judge Michael A. Shipp that the investors' federal Securities Exchange Act claims should be barred because of the Exchange Act's two-year statute of limitations.

"Plaintiffs filed this action more than three and a half years after...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!